Response of Diabetic Papillopathy to Intravitreal Bevacizumab

Diabetic papillopathy is an uncommon hyperemic optic disc swelling that occurs in patients with long-standing diabetes, is typically self-resolving with minimal effect on vision, and is likely ischemic in origin. The purpose of the current report is to document the response of diabetic papillopathy...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Dhibi, Hassan, Khan, Arif O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162739/
https://www.ncbi.nlm.nih.gov/pubmed/21887082
http://dx.doi.org/10.4103/0974-9233.84056
Descripción
Sumario:Diabetic papillopathy is an uncommon hyperemic optic disc swelling that occurs in patients with long-standing diabetes, is typically self-resolving with minimal effect on vision, and is likely ischemic in origin. The purpose of the current report is to document the response of diabetic papillopathy to intravitreal injection of bevacizumab (Avastin, Genentech Inc, San Francisco, California, USA), a humanized monoclonal antibody to vascular endothelial growth factor.

Ejemplares similares